STAY UP TO DATE
Join our FREE network for latest news, events, training, research, sponsorship opportunities and more
Siren brief project overview
Evaluation of the Western Australian PrEP Trial.
2017 - present.
Dr Roanna Lobo (Curtin University), Ms Myra Robinson (Curtin University).
The aim of the proposed evaluation is to investigate the experiences of WA service providers involved in the WA PrEP trial at the four trial sites: Royal Perth Hospital Sexual Health Clinic, South Terrace Sexual Health Clinic (Fremantle), GP on Beaufort, and M Clinic. Service providers will include doctors, prescribers, peer workers and nurses.
The objectives of the evaluation are:
- To investigate the short term impacts of the PrEP trial for service providers including changes in workload, establishing trial data collection processes, any knowledge and skills requirements to engage participants, and reorientation of clinic services.
- To determine requirements for offering PrEP to regional or remote trial participants, including the use of telehealth service to liaise and provide support to patients.
- To identify unanticipated implementation challenges and inform appropriate responses.
- To determine whether attitudes and expectations of service providers related to delivering PrEP have been met or have changed.
- To contribute new insights related to providing PrEP and how this fits into existing clinic services.
- To understand the long term implications of PrEP service provision including any similarities and differences between trial sites.
WA Department of Health Sexual Health and Blood Borne Virus Program.
SiREN have been commissioned by the WA AIDS Council and the Kirby Institute to undertake an independent evaluation of the previously mentioned areas of the PrEP Trial.
Project outputs and impacts
It is expected that the evaluation of the PrEP trial will provide important information on a number of factors through mixed method data collection using a variety of strategies including interviews, surveys, workshops and focus groups. Data collected will include an exploration of the attitudes and expectations of the service providers of the drugs used in the trial at the start of the trial and how these changed after a year of the trial running. The positive and negative impacts of implementing the trial for service providers and assessing the successful of the training for those providers, along with implementation solutions and challenges, and new insights into PrEP as part of a clinical setting. Finally, information will be collected regarding the strategies that other services providers could use in the future, including those in regional and remote areas in order to facilitate the uptake of PrEP in those areas.
Evaluation reports and further publications will be submitted as the study progresses.